119-hr1064

HR
✓ Complete Data

Stopping Overdoses of Fentanyl Analogues Act

Login to track bills
Introduced:
Feb 6, 2025
Policy Area:
Crime and Law Enforcement

Bill Statistics

4
Actions
0
Cosponsors
1
Summaries
3
Subjects
1
Text Versions
Yes
Full Text

AI Summary

No AI Summary Available

Click the button above to generate an AI-powered summary of this bill using Claude.

The summary will analyze the bill's key provisions, impact, and implementation details.

Latest Action

Feb 6, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Summaries (1)

Introduced in House - Feb 6, 2025 00
<p><strong>Stopping Overdoses of Fentanyl Analogues Act</strong></p><p>This bill permanently adds fentanyl-related substances to schedule I of the Controlled Substances Act. (A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)</p><p>Fentanyl-related substances are currently regulated under schedule I through a temporary order issued by the Drug Enforcement Administration. The temporary order expires March 31, 2025.</p>

Actions (4)

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Type: IntroReferral | Source: House floor actions | Code: H11100
Feb 6, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Type: IntroReferral | Source: House floor actions | Code: H11100
Feb 6, 2025
Introduced in House
Type: IntroReferral | Source: Library of Congress | Code: Intro-H
Feb 6, 2025
Introduced in House
Type: IntroReferral | Source: Library of Congress | Code: 1000
Feb 6, 2025

Subjects (3)

Crime and Law Enforcement (Policy Area) Criminal procedure and sentencing Drug trafficking and controlled substances

Text Versions (1)

Introduced in House

Feb 6, 2025

Full Bill Text

Length: 3,325 characters Version: Introduced in House Version Date: Feb 6, 2025 Last Updated: Nov 8, 2025 6:21 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1064 Introduced in House

(IH) ]

<DOC>

119th CONGRESS
1st Session
H. R. 1064

To amend the Controlled Substances Act to list fentanyl-related
substances as schedule I controlled substances.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

February 6, 2025

Mr. Fitzgerald introduced the following bill; which was referred to the
Committee on Energy and Commerce, and in addition to the Committee on
the Judiciary, for a period to be subsequently determined by the
Speaker, in each case for consideration of such provisions as fall
within the jurisdiction of the committee concerned

_______________________________________________________________________

A BILL

To amend the Controlled Substances Act to list fentanyl-related
substances as schedule I controlled substances.

Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1.

This Act may be cited as the ``Stopping Overdoses of Fentanyl
Analogues Act''.
SEC. 2.
Section 202 (c) of the Controlled Substances Act (21 U.
(c) of the Controlled Substances Act (21 U.S.C. 812
(c) )
is amended by adding at the end of schedule I the following:
``

(e)

(1) Unless specifically exempted or unless listed in another
schedule, any material, compound, mixture, or preparation which
contains any quantity of fentanyl-related substances, or which contains
their salts, isomers, and salts of isomers whenever the existence of
such salts, isomers, and salts of isomers is possible within the
specific chemical designation.
``

(2) In paragraph

(1) , the term `fentanyl-related substances'
includes any substance that is structurally related to fentanyl by one
or more of the following modifications:
``
(A) By replacement of the phenyl portion of the phenethyl
group by any monocycle, whether or not further substituted in
or on the monocycle.
``
(B) By substitution in or on the phenethyl group with
alkyl, alkenyl, alkoxy, hydroxy, halo, haloalkyl, amino or
nitro groups.
``
(C) By substitution in or on the piperidine ring with
alkyl, alkenyl, alkoxy, ester, ether, hydroxy, halo, haloalkyl,
amino or nitro groups.
``
(D) By replacement of the aniline ring with any aromatic
monocycle whether or not further substituted in or on the
aromatic monocycle.
``
(E) By replacement of the N-propionyl group by another
acyl group.''.
SEC. 3.

A fentanyl-related substance shall be treated as an analogue of N-
phenyl-N-[1-(2-phenylethyl)-4-piperidinyl] propanamide under
section 401 (b) (1) of the Controlled Substances Act (21 U.

(b)

(1) of the Controlled Substances Act (21 U.S.C. 841

(b)

(1) ) and
section 1010 (b) of the Controlled Substances Import and Export Act (21 U.

(b) of the Controlled Substances Import and Export Act (21
U.S.C. 960

(b) ) without requiring proof that a fentanyl-related
substance meets the definition of a controlled substance analogue under
section 102 of the Controlled Substances Act (21 U.
SEC. 4.

This Act shall take effect one day after the date of enactment of
this Act.
<all>